ABT compared with CBT: revenue, margins and what each company keeps, and the suppliers and customers both name

ABTAbbott Laboratories

Mkt capRevenueRevenue

CBTCabot Corp

Mkt capRevenueRevenue

Compare

ABTAbbott Laboratories

CBTCabot Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ABT

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.3%▼−1.89%×0.36

Q2 FY26±4.3%▲+10.71%×2.49

Q1 FY26±4.4%▼−6.00%×1.36

Jan 22 '26±3.2%▼−10.04%×3.13

CBT

2 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 3 '26±7.2%▼−4.91%×0.68

Q3 FY26±6.0%▼−8.51%×1.42

= impliedABT realized, solidCBT realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q2 FY26

±6.4%

▲+4.41%

×0.69

Feb 4 '26±6.3%▲+10.44%×1.65

ABTAbbott Laboratories

110.04▼−3.14%· post 109.82

Mkt cap$190.4BRevenue$13.0BQ3 FY26Revenue$44.3BFY25

CBTCabot Corp

71.20▼−2.43%· post 71.20

ClosedNov 6 '26

Mkt cap$3.7BRevenue$982MQ3 FY26Revenue$3.7BFY25

Compare

ClosedNov 6 '26

ABTAbbott Laboratories

CBTCabot Corp

110.04▼−3.14%post 109.82

Price

71.20▼−2.43%post 71.20

$190.4B

Mkt cap

$3.7B

Q3 FY26$13.0B

Revenue

$982MQ3 FY26

FY25$44.3B

Revenue

$3.7BFY25

ABT110.04▼−3.14%vsCBT71.20▼−2.43%ClosedNov 6 '26